Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test

Vaccine

Volumn 19, Issue 9-10, 2000, Pages 1246-1255

  Vordermeier, H M ^a   Cockle, P J ^a   Whelan, A O ^a   Rhodes, S ^a   Chambers, M A ^a   Clifford, D ^a   Huygen, K ^b   Tascon, R ^c   Lowrie, D ^c   Colston, M J ^c   Hewinson, R G ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Bovine tuberculosis; Cattle; Vaccination

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; BCG VACCINE; CD4 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CATTLE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; INFECTION CONTROL; NONHUMAN; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULIN TEST; VACCINATION; VALIDATION PROCESS;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CATTLE; FEMALE; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; TUBERCULIN TEST; VACCINATION; VACCINES, DNA;

EID: 0034623976     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00238-3     Document Type: Article

References (63)

1. Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa
2. Mycobacterium bovis in England and Wales: Past, present and future
3. HIV-related tuberculosis due to Mycobacterium bovis
4. The bovine tuberculosis cycle - An African perspective
5. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries
6. Mycobacterium bovis infections in San Diego: A clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen
7. Regional and Country Status Reports. Introduction
8. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG
9. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae
10. Vaccination against tuberculosis by DNA injection
11. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
12. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
13. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors
14. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection
15. Therapy of tuberculosis in mice by DNA vaccination
16. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle
17. Comparison of DNA application methods to reduce BRSV shedding in cattle
18. DNA immunization with bovine herpesvirus-1 genes
19. Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA
20. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV
21. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
22. Molecular characterization of MPT83: A seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70
23. Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate
24. Purification of a major Mycobacterium bovis antigen for the diagnosis of bovine tuberculosis
25. Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis
26. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
27. Biological activity in sensitized guinea pigs of MPB 70, a protein specific for some strains of Mycobacterium bovis BCG
28. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens
29. Serological reactivity to Mycobacterium bovis protein antigens in cattle
30. Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57
31. Immunoblot analysis of humoral immune responses to Mycobacterium bovis in experimentally infected cattle: Early recognition of a 26-kilodalton antigen
32. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle
33. Recognition of a common mycobacterial T-cell epitope in MPB59 of Mycobacterium bovis
34. Bovine tuberculosis: Immune responses in the peripheral blood and at the site of active disease
35. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
36. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83
37. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
38. Community EE, EEC directive 80/219 EEC, amending directive 64/432 annexe B
39. In vitro immunodiagnostic assays for bovine tuberculosis
40. Summary of third ruminant leukocyte workshop findings
41. Analysis of monoclonal antibodies specific for the gamma delta TcR
42. Serodiagnosis of Mycobacterium bovis infection in badgers: Development of an indirect ELISA using a 25 kDa antigen
43. Confidence intervals for means
44. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain
45. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection
46. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity
47. DNA and CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells
48. Immune mechanisms of protection
49. + T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis
50. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection
51. Relation between delayed hypersensitivity and immunity in tuberculosis
52. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene
53. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines
54. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity
55. + cells with memory for intestinal rotavirus
56. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation
57. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis
58. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
59. Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
60. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
61. + T cell immunogenicity and protective efficacy in the influenza and malaria models
62. Experimental Mycobacterium bovis infection of cattle: Effect of dose of M. bovis and pregnancy on immune responses and distributios of lesions